• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SIRT5 是一种前病毒因子,可与 SARS-CoV-2 Nsp14 蛋白相互作用。

SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein.

机构信息

Buck Institute for Research on Aging, Novato, California, United States of America.

Gladstone Institutes, San Francisco, California, United States of America.

出版信息

PLoS Pathog. 2022 Sep 12;18(9):e1010811. doi: 10.1371/journal.ppat.1010811. eCollection 2022 Sep.

DOI:10.1371/journal.ppat.1010811
PMID:36095012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9499238/
Abstract

SARS-CoV-2 non-structural protein Nsp14 is a highly conserved enzyme necessary for viral replication. Nsp14 forms a stable complex with non-structural protein Nsp10 and exhibits exoribonuclease and N7-methyltransferase activities. Protein-interactome studies identified human sirtuin 5 (SIRT5) as a putative binding partner of Nsp14. SIRT5 is an NAD-dependent protein deacylase critical for cellular metabolism that removes succinyl and malonyl groups from lysine residues. Here we investigated the nature of this interaction and the role of SIRT5 during SARS-CoV-2 infection. We showed that SIRT5 interacts with Nsp14, but not with Nsp10, suggesting that SIRT5 and Nsp10 are parts of separate complexes. We found that SIRT5 catalytic domain is necessary for the interaction with Nsp14, but that Nsp14 does not appear to be directly deacylated by SIRT5. Furthermore, knock-out of SIRT5 or treatment with specific SIRT5 inhibitors reduced SARS-CoV-2 viral levels in cell-culture experiments. SIRT5 knock-out cells expressed higher basal levels of innate immunity markers and mounted a stronger antiviral response, independently of the Mitochondrial Antiviral Signaling Protein MAVS. Our results indicate that SIRT5 is a proviral factor necessary for efficient viral replication, which opens novel avenues for therapeutic interventions.

摘要

SARS-CoV-2 的非结构蛋白 Nsp14 是一种高度保守的酶,对病毒复制是必需的。Nsp14 与非结构蛋白 Nsp10 形成稳定的复合物,并表现出外切核酸酶和 N7-甲基转移酶活性。蛋白质相互作用研究鉴定出人源 SIRT5(Sirtuin 5)为 Nsp14 的一个假定结合伴侣。SIRT5 是一种 NAD 依赖性蛋白去酰化酶,对于细胞代谢至关重要,它可以从赖氨酸残基上去除琥珀酰基和丙二酰基。在这里,我们研究了这种相互作用的性质以及 SIRT5 在 SARS-CoV-2 感染过程中的作用。我们表明 SIRT5 与 Nsp14 相互作用,但不与 Nsp10 相互作用,这表明 SIRT5 和 Nsp10 是不同复合物的组成部分。我们发现 SIRT5 的催化结构域对于与 Nsp14 的相互作用是必需的,但 Nsp14 似乎不是由 SIRT5 直接去酰化的。此外,在细胞培养实验中,SIRT5 的敲除或使用特定的 SIRT5 抑制剂处理降低了 SARS-CoV-2 的病毒水平。SIRT5 敲除细胞表达更高的基础水平的先天免疫标志物,并独立于线粒体抗病毒信号蛋白 MAVS 产生更强的抗病毒反应。我们的结果表明,SIRT5 是一种促进病毒复制的有利因素,这为治疗干预开辟了新的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/67d44e0e3663/ppat.1010811.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/ca80dbd07160/ppat.1010811.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/542853667207/ppat.1010811.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/b52948966f38/ppat.1010811.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/43f06f076928/ppat.1010811.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/58906cca3d8d/ppat.1010811.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/11e3dc1fc044/ppat.1010811.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/1b72d4b2c090/ppat.1010811.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/67d44e0e3663/ppat.1010811.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/ca80dbd07160/ppat.1010811.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/542853667207/ppat.1010811.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/b52948966f38/ppat.1010811.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/43f06f076928/ppat.1010811.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/58906cca3d8d/ppat.1010811.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/11e3dc1fc044/ppat.1010811.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/1b72d4b2c090/ppat.1010811.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/9499238/67d44e0e3663/ppat.1010811.g008.jpg

相似文献

1
SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein.SIRT5 是一种前病毒因子,可与 SARS-CoV-2 Nsp14 蛋白相互作用。
PLoS Pathog. 2022 Sep 12;18(9):e1010811. doi: 10.1371/journal.ppat.1010811. eCollection 2022 Sep.
2
SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein.SIRT5是一种与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)Nsp14蛋白相互作用的前病毒因子。
bioRxiv. 2022 Jan 5:2022.01.04.474979. doi: 10.1101/2022.01.04.474979.
3
New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2.药物设计的新靶点:nsp14/nsp10 复合物形成对于 SARS-CoV-2 的 3'-5' 外切核糖核酸酶活性的重要性。
FEBS J. 2021 Sep;288(17):5130-5147. doi: 10.1111/febs.15815. Epub 2021 Apr 28.
4
Activation of the SARS-CoV-2 NSP14 3'-5' exoribonuclease by NSP10 and response to antiviral inhibitors.SARS-CoV-2 NSP14 3'-5' 外切核糖核酸酶的激活及其对抗病毒抑制剂的反应。
J Biol Chem. 2022 Jan;298(1):101518. doi: 10.1016/j.jbc.2021.101518. Epub 2021 Dec 20.
5
Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug development.SARS-CoV-2 NSP14 的晶体结构和片段筛选揭示了外切核酸酶激活和 mRNA 加帽的详细信息,并为抗病毒药物的开发提供了起点。
Nucleic Acids Res. 2023 Jan 11;51(1):475-487. doi: 10.1093/nar/gkac1207.
6
Crystal structure of SARS-CoV-2 nsp10 bound to nsp14-ExoN domain reveals an exoribonuclease with both structural and functional integrity.SARS-CoV-2 nsp10 与 nsp14-ExoN 结构域复合物的晶体结构揭示了具有结构和功能完整性的外切核酸酶。
Nucleic Acids Res. 2021 May 21;49(9):5382-5392. doi: 10.1093/nar/gkab320.
7
Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes.冠状病毒Nsp10,多种复制酶激活的关键辅助因子。
J Biol Chem. 2014 Sep 12;289(37):25783-96. doi: 10.1074/jbc.M114.577353. Epub 2014 Jul 29.
8
Reconstitution and functional characterization of SARS-CoV-2 proofreading complex.SARS-CoV-2 校对复合物的重建与功能表征。
Protein Expr Purif. 2021 Sep;185:105894. doi: 10.1016/j.pep.2021.105894. Epub 2021 Apr 29.
9
The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2.nsp14 外切核酸酶的酶活性对于 MERS-CoV 和 SARS-CoV-2 的复制至关重要。
J Virol. 2020 Nov 9;94(23). doi: 10.1128/JVI.01246-20.
10
Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification.SARS-CoV-2 外切核酸酶(nsp14ExoN-nsp10)复合物的特性:对其在病毒基因组稳定性和抑制剂鉴定中的作用的影响。
Nucleic Acids Res. 2022 Feb 22;50(3):1484-1500. doi: 10.1093/nar/gkab1303.

引用本文的文献

1
Expression of metabolic genes in NK cells is associated with clinical outcomes in patients with severe COVID-19: a brief report.自然杀伤细胞中代谢基因的表达与重症 COVID-19 患者的临床结局相关:简要报告
Front Cell Infect Microbiol. 2025 Aug 25;15:1636463. doi: 10.3389/fcimb.2025.1636463. eCollection 2025.
2
Unveiling genetic signatures of immune response in immune-related diseases through single-cell eQTL analysis across diverse conditions.通过跨多种条件的单细胞eQTL分析揭示免疫相关疾病中免疫反应的基因特征。
Nat Commun. 2025 Aug 4;16(1):7134. doi: 10.1038/s41467-025-61192-4.
3
The function and mechanism of protein acylation in the regulation of viral infection.

本文引用的文献

1
Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme.新冠病毒校对酶错配识别的结构基础
Science. 2021 Sep 3;373(6559):1142-1146. doi: 10.1126/science.abi9310. Epub 2021 Jul 27.
2
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.SARS-CoV-2 感染 ACE2 阴性人呼吸道细胞的系统分析。
Cell Rep. 2021 Jul 13;36(2):109364. doi: 10.1016/j.celrep.2021.109364. Epub 2021 Jun 23.
3
Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading.
蛋白质酰化在病毒感染调控中的作用及机制。
Virulence. 2025 Dec;16(1):2530171. doi: 10.1080/21505594.2025.2530171. Epub 2025 Jul 17.
4
SIRT5-mediated desuccinylation of the porcine deltacoronavirus M protein drives pexophagy to enhance viral proliferation.SIRT5介导的猪德尔塔冠状病毒M蛋白去琥珀酰化驱动细胞自噬以增强病毒增殖。
PLoS Pathog. 2025 May 9;21(5):e1013163. doi: 10.1371/journal.ppat.1013163. eCollection 2025 May.
5
Impact of SARS-CoV-2 Wuhan and Omicron Variant Proteins on Type I Interferon Response.严重急性呼吸综合征冠状病毒2型武汉株和奥密克戎变异株蛋白对I型干扰素反应的影响。
Viruses. 2025 Apr 15;17(4):569. doi: 10.3390/v17040569.
6
NAD+ Suppresses EV-D68 Infection by Enhancing Anti-Viral Effect of SIRT1.烟酰胺腺嘌呤二核苷酸(NAD+)通过增强沉默调节蛋白1(SIRT1)的抗病毒作用来抑制肠道病毒D68型(EV-D68)感染。
Viruses. 2025 Jan 26;17(2):175. doi: 10.3390/v17020175.
7
SIRT5: a potential target for discovering bioactive natural products.沉默调节蛋白5:发现生物活性天然产物的潜在靶点。
J Nat Med. 2025 May;79(3):441-464. doi: 10.1007/s11418-024-01871-6. Epub 2025 Feb 20.
8
Decoding NAD+ Metabolism in COVID-19: Implications for Immune Modulation and Therapy.解析新冠病毒感染中的NAD+代谢:对免疫调节和治疗的意义
Vaccines (Basel). 2024 Dec 24;13(1):1. doi: 10.3390/vaccines13010001.
9
Drugs Targeting Sirtuin 2 Exhibit Broad-Spectrum Anti-Infective Activity.靶向沉默调节蛋白2的药物具有广谱抗感染活性。
Pharmaceuticals (Basel). 2024 Sep 29;17(10):1298. doi: 10.3390/ph17101298.
10
Oncogenic potential of SARS-CoV-2-targeting hallmarks of cancer pathways.靶向 SARS-CoV-2 癌症通路标志性特征的致癌潜力。
Cell Commun Signal. 2024 Sep 26;22(1):447. doi: 10.1186/s12964-024-01818-0.
N7-甲基转移酶和3'-5'外切核糖核酸酶与新冠病毒聚合酶的偶联揭示了加帽和校对机制。
Cell. 2021 Jun 24;184(13):3474-3485.e11. doi: 10.1016/j.cell.2021.05.033. Epub 2021 May 24.
4
SARS-CoV-2 Nsp14 activates NF-κB signaling and induces IL-8 upregulation.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白14(Nsp14)激活核因子κB(NF-κB)信号通路并诱导白细胞介素-8(IL-8)上调。
bioRxiv. 2021 May 26:2021.05.26.445787. doi: 10.1101/2021.05.26.445787.
5
Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein.SARS-CoV-2 NSP14 蛋白介导的翻译抑制和固有免疫逃避。
Proc Natl Acad Sci U S A. 2021 Jun 15;118(24). doi: 10.1073/pnas.2101161118.
6
RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells.RIG-I 在人肺细胞中触发信号转导失败的抗 SARS-CoV-2 防御。
Nat Immunol. 2021 Jul;22(7):820-828. doi: 10.1038/s41590-021-00942-0. Epub 2021 May 11.
7
Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities.系统功能分析 SARS-CoV-2 蛋白揭示了病毒先天免疫拮抗剂和剩余弱点。
Cell Rep. 2021 May 18;35(7):109126. doi: 10.1016/j.celrep.2021.109126. Epub 2021 Apr 27.
8
Innate immune sensing of coronavirus and viral evasion strategies.先天免疫感知冠状病毒和病毒逃避策略。
Exp Mol Med. 2021 May;53(5):723-736. doi: 10.1038/s12276-021-00602-1. Epub 2021 May 6.
9
Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer.药理学和基因干扰研究表明,SIRT5是乳腺癌一个有前景的治疗靶点。
Oncogene. 2021 Mar;40(9):1644-1658. doi: 10.1038/s41388-020-01637-w. Epub 2021 Jan 21.
10
The coronavirus proofreading exoribonuclease mediates extensive viral recombination.冠状病毒校对外切核糖核酸酶介导广泛的病毒重组。
PLoS Pathog. 2021 Jan 19;17(1):e1009226. doi: 10.1371/journal.ppat.1009226. eCollection 2021 Jan.